←
Amy Beumer, Ph.D.2,463 posts
Amy Beumer, Ph.D. avatar

Amy Beumer, Ph.D.

@amybeumer

MBC advocate, microbiologist, educator, nature lover, gardener, reader, and feminist. She/her/hers.

◷ Joined May 2014▧ 108 Photos and videos
Amy Beumer, Ph.D. avatar
Amy Beumer, Ph.D.@amybeumer·19 Dec 2025

Recovering from #SABCS25 (and working on a report back) and want to say thank you to all the researchers who presented and/or had any part in presented work. It's truly amazing the dedication and hard work by so many people. Appreciate you all!

Amy Beumer, Ph.D. avatar
Amy Beumer, Ph.D.@amybeumer·13 Dec 2025

If I remember correctly this happened last year as well….disappointing doesn’t quite cover it.

This tweet is unavailable

Christine Hodgdon avatar
⟳ Amy Beumer, Ph.D. retweeted
Christine Hodgdon@christeeny513·11 Dec 2025

Patient advocate Samantha Horn opens with a powerful question: “what were you doing in your 20s?” For her, it was chemo. ICYMI, this is a must-watch educational session on breast cancer in young women. #sabcs25 #oncoalert

Post attachment
Dr. Kelly Shanahan avatar
⟳ Amy Beumer, Ph.D. retweeted
Dr. Kelly Shanahan@stage4kelly·9 Dec 2025

Grateful to @christeeny513 for sharing her story - and how her concerns of a lump were initially dismissed with something far too many hear: “you’re too young for breast cancer”. No one is too young and everyone deserves to have their concerns addressed. #SABCS25 #bcsm

Post attachment
Dr. Kelly Shanahan avatar
⟳ Amy Beumer, Ph.D. retweeted
Dr. Kelly Shanahan@stage4kelly·9 Dec 2025

This exactly what we need - guidance to mitigate the side effects from our treatments. Many of us start antihistamines a few days before beginning capi and never have to deal with the rash. And for those super sensitive to loperamide 🙋‍♀️off label crofelemer can be a game changer.

As we kick off #SABCS25, excited to share our new recommendations paper for capivasertib in HR+ MBC: 10 practical recommendations to optimize treatment and patient experience. nature.com/articles/s41523-0… @HeatherMoore16 @ErikaHamilton9 @jhaveri_komal @hoperugo @WinshipAtEmory

Harold J. Burstein, MD, PhD, FASCO avatar
⟳ Amy Beumer, Ph.D. retweeted
Harold J. Burstein, MD, PhD, FASCO@DrHBurstein·13 Nov 2025

This is going viral!! Join us tomorrow at 1:30 PM EST. Free to watch but registration required at link below.

What are the most important takeaways from #ESMO25 for #BreastCancer care? Join @DanaFarber experts on Nov 14th for our live #BreastCancerBreakthroughs webinar discussing the latest clinical advances, research highlights, and their impact on patient care. 📅November 14, 1:30–2:30 PM EST 👉Register for free today: bit.ly/3WvQUhi Moderator: @DrHBurstein Panelists: @stolaney1 @nlinmd @FilipaLynce #AnaGarridoCastro

Post attachment
Amy Beumer, Ph.D. avatar
Amy Beumer, Ph.D.@amybeumer·13 Nov 2025

Raising the bar is what I like to hear. Helpful algorithm too- thank you Dr. Sammons #bcsm

I gave a talk this weekend at Curio Expert Meeting in Tampa, FL with the task of educating the community on updates in ER+, HER2- MBC. It is getting to be quite the challenge! Here are my thoughts on likely algorithms in 2026. The bar is getting higher on safety and efficacy.

Post attachment
Janice Cowden avatar
⟳ Amy Beumer, Ph.D. retweeted
Janice Cowden@JaniceTNBCmets·1 Nov 2025

Share your MBC side effects & experiences in this MBC patient-led survey from PCDI. Your MBC story can help PCDI work to improve treatment dosing, clinical trial design, and quality of life on long-term treatment.  E-mail surveys @ therightdose . org to get a personal link (copy, paste & delete the extra spaces) #metastaticbreastcancer #bcsm #research #QoL

Post attachment
Dr. Kelly Shanahan avatar
⟳ Amy Beumer, Ph.D. retweeted
Dr. Kelly Shanahan@stage4kelly·31 Oct 2025

MBC doesn’t stop just because October ends. Neither does the need for research.

As October ends and pink ribbons fade, we cannot forget Stage IV—not for a single day. Only 13% of breast cancer research funding goes to the disease that kills. Thank you for following our #METober posts. Please keep sharing and spreading the word #UntilNoOneDiesFromMBC

Post attachment
Yakup Ergün avatar
⟳ Amy Beumer, Ph.D. retweeted
Yakup Ergün@dr_yakupergun·20 Oct 2025

#ESMO25 🇪🇸 GEICAM “El Álamo” (n=22,989) Anthracycline-based chemotherapy significantly increased the risk of contralateral breast cancer and second primary malignancies (IRR 1.46; p=0.039). 💬 Real-world data remind us once again: long-term toxicity cannot be ignored.

Post attachment

Ask any breast oncologist today, and they’ll tell you they prefer anthracycline-free regimens in HER2-positive breast cancer — and that anthracyclines don’t improve response rates. So how did we accept a control arm containing anthracyclines in the DESTINY-Breast11 trial, which began in October 2021? We can’t simply call this a sponsor-driven choice. It’s the physicians who persuade patients to enroll — physicians who also receive payment for every screening and treatment visit. Let’s be honest: how do you justify to your patients a control arm that doesn’t reflect your own real-world practice? I’m open to any kind of criticism; just don’t come to me with the fairytale that anthracycline-containing arms are still the “standard.” I know this sounds a bit harsh, but we’re exhausted from having to point out flaws in control arms every time new trial results are presented. We’re now seeing control arms that no longer represent today’s standards — some even belong to history (eg. ARANOTE trial). It’s a call to all of us, as physicians, to think more carefully about the trials we support — if our genuine goal is the health and well-being of every patient, including those in the control arm.

Post attachment
Dr. Kelly Shanahan avatar
⟳ Amy Beumer, Ph.D. retweeted
Dr. Kelly Shanahan@stage4kelly·20 Oct 2025

Grateful to all our elected representatives who understand the need for research funding and supporting bills that help the MBC community. @RepJoeMorelle I’m so sorry you know the pain of having a loved one stolen by MBC far, far too soon.

Rep. Joe Morelle shares a powerful message at the Stage IV Stampede, honoring his daughter and urging support for MBC legislation. Read more on our blog here: metavivor.org/advocacy-in-ac… #StageIVStampede #MBCAdvocacy

1:34
Dr. Kelly Shanahan avatar
⟳ Amy Beumer, Ph.D. retweeted
Dr. Kelly Shanahan@stage4kelly·21 Oct 2025

I’ve been in the liver met “club” for a year or so now, thankfully responding to the treatment targeted to mutations my cancer has. I’m alive and doing pretty darn well thanks to #research. Please support @metavivor #UntilNoOneDiesFromMBC

About two-thirds of MBC patients have liver metastases at death, and 1 in 4 already have liver involvement at diagnosis. Liver transplants aren’t an option for MBC patients—another reason why we need more research for better treatments. #UntilNoOneDeisFromMBC #Research

Post attachment